Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
Nuclear contract signals: BWX Technologies, Inc. is a U.S.-based manufacturing and engineering company focused on nuclear solutions for global security, clean energy, nuclear medicine, space exploration and environmental restoration. BWXT news is shaped by awards and shipments tied to the U.S. Naval Nuclear Propulsion Program, commercial nuclear component capacity, fuel and fuel handling, TRISO and HALEU fuel work, and NRC engagement for uranium enrichment licensing.
Investors should compare future BWXT updates across Government Operations and Commercial Operations, with attention to backlog drivers, manufacturing capacity, contract timing, regulatory milestones and acquisition-related expansion in nuclear components and services.
BWX Technologies (NYSE:BWXT) has achieved a significant milestone in advanced nuclear fuel manufacturing with the completion of a chemical vapor infiltration (CVI) furnace installation. This advancement enables BWXT to produce enhanced TRISO nuclear fuel, described by the DOE as "the most robust nuclear fuel on Earth."
The new capability allows BWXT to load Uranium Nitride TRISO into additively manufactured fuel forms, resulting in higher uranium mass per unit volume than traditional TRISO compacts. This innovation promises more cost-effective fuel with longer reactor lifespans. The company currently produces both Uranium Oxy Carbide TRISO for Project Pele and UN TRISO for the Advanced Reactor Demonstration Program (ARDP), with plans to expand production to support the BWXT Advanced Nuclear Reactor (BANR) program.
BWX Technologies (NYSE: BWXT) has secured significant U.S. Naval Nuclear Propulsion Program contracts worth approximately $2.6 billion, including future year options, for manufacturing naval nuclear reactor components. The contracts primarily support Virginia and Columbia-class submarines and Ford-class aircraft carrier components, with deliveries scheduled over the next 6-8 years.
These new contracts build upon the $2.1 billion in awards announced in February. BWXT, with facilities across Ohio, Indiana, Tennessee, and Virginia, manufactures and assembles highly complex naval nuclear reactors, including large components, finely machined parts, and highly enriched uranium fuel.
BWX Technologies (NYSE:BWXT) has scheduled its second quarter 2025 earnings release and conference call for Monday, August 4, 2025. The company will release results after market close, followed by a conference call at 5:00 p.m. EDT.
Participants can join via webcast at investors.bwxt.com or by phone using the following dial-in numbers: (U.S.) 1-888-596-4144 and (International) 1-646-968-2525 with conference ID: 3934110.
BWXT is a Fortune 1000 and Defense News Top 100 company specializing in nuclear solutions for global security, clean energy, environmental restoration, nuclear medicine, and space exploration. The company employs nearly 10,000 people across 20 major operating sites in the U.S., Canada, and the U.K.
BWX Technologies (NYSE: BWXT) has completed its acquisition of Kinectrics, Inc. on May 20, 2025. The strategic acquisition significantly enhances BWXT's capabilities in the commercial nuclear power market and medical isotopes sector. Kinectrics provides nuclear power plant lifecycle support services, particularly for CANDU reactors, and serves the transmission and distribution markets along with radiopharmaceutical isotope production.
The acquisition nearly doubles BWXT's Commercial Operations group workforce and expands its product and service portfolio. Kinectrics will operate as a BWXT subsidiary within the Commercial Operations segment, with David Harris continuing as president & CEO, reporting to BWXT Commercial Operations president John MacQuarrie.
BWX Technologies (NYSE: BWXT) has acquired 97 acres in Oak Ridge, Tennessee's Horizon Center Industrial Park, advancing its commitment to rebuild domestic uranium enrichment capabilities. The strategic acquisition supports the U.S. Department of Energy's National Nuclear Security Administration (NNSA) and the deployment of Domestic Uranium Enrichment Centrifuge Experiment (DUECE) technology.
The project aims to establish advanced centrifuge manufacturing capabilities and specialized support services, projected to create hundreds of jobs over the next decade and generate millions in investments. BWXT received a year-long engineering contract in August 2024 to evaluate options for deploying a centrifuge pilot plant.
This initiative addresses a critical national security need, as the U.S. Government currently lacks uranium enrichment capabilities for defense missions. The DUECE program, developed by Oak Ridge National Laboratory, seeks to establish a reliable domestic supply of enriched uranium for national security requirements.